Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Adjuvant activity of CpG-ODN formulated as a liquid crystal.

Sánchez Vallecillo MF, Ullio Gamboa GV, Palma SD, Harman MF, Chiodetti AL, Morón G, Allemandi DA, Pistoresi-Palencia MC, Maletto BA.

Biomaterials. 2014 Mar;35(8):2529-42. doi: 10.1016/j.biomaterials.2013.12.002. Epub 2013 Dec 30.

PMID:
24382332
[PubMed - in process]
2.

A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine.

Sugai T, Mori M, Nakazawa M, Ichino M, Naruto T, Kobayashi N, Kobayashi Y, Minami M, Yokota S.

Vaccine. 2005 Nov 16;23(46-47):5450-6. Epub 2005 Jun 21.

PMID:
16006019
[PubMed - indexed for MEDLINE]
3.
4.

Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice.

Alignani D, Maletto B, Liscovsky M, Rópolo A, Morón G, Pistoresi-Palencia MC.

J Leukoc Biol. 2005 Jun;77(6):898-905. Epub 2005 Mar 9.

PMID:
15758079
[PubMed - indexed for MEDLINE]
Free Article
5.

The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice.

Kovacs-Nolan J, Latimer L, Landi A, Jenssen H, Hancock RE, Babiuk LA, van Drunen Littel-van den Hurk S.

Vaccine. 2009 Mar 23;27(14):2055-64. doi: 10.1016/j.vaccine.2009.01.118. Epub 2009 Feb 2.

PMID:
19428830
[PubMed - indexed for MEDLINE]
6.

Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.

Oumouna M, Mapletoft JW, Karvonen BC, Babiuk LA, van Drunen Littel-van den Hurk S.

J Virol. 2005 Feb;79(4):2024-32.

PMID:
15681404
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.

Mutwiri G, Benjamin P, Soita H, Babiuk LA.

Vaccine. 2008 May 23;26(22):2680-8. doi: 10.1016/j.vaccine.2008.03.031. Epub 2008 Apr 3.

PMID:
18430493
[PubMed - indexed for MEDLINE]
8.

[CpG-ODN is a potential candidate adjuvant for human vaccines].

Xu H, Wang S, Guo F, Lu R, Ruan L.

Zhonghua Yi Xue Za Zhi. 2002 Apr 25;82(8):553-6. Chinese.

PMID:
12133504
[PubMed - indexed for MEDLINE]
9.

CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations.

Van der Stede Y, Verdonck F, Vancaeneghem S, Cox E, Goddeeris BM.

Vet Immunol Immunopathol. 2002 May;86(1-2):31-41.

PMID:
11943328
[PubMed - indexed for MEDLINE]
10.

CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.

Davis HL, Weeratna R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM.

J Immunol. 1998 Jan 15;160(2):870-6. Erratum in: J Immunol 1999 Mar 1;162(5):3103. Weeranta R [corrected to Weeratna R].

PMID:
9551923
[PubMed - indexed for MEDLINE]
Free Article
11.

[Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].

Chen H, Deng Y, Tan W, Wang W, Yin X, Guan J, Wang W, Ruan L.

Sheng Wu Gong Cheng Xue Bao. 2010 Jan;26(1):74-8. Chinese.

PMID:
20353095
[PubMed - indexed for MEDLINE]
12.

Immunization of aged pigs with attenuated pseudorabies virus vaccine combined with CpG oligodeoxynucleotide restores defective Th1 immune responses.

Ming F, Yang J, Chu P, Ma M, Shi J, Cai H, Huang C, Li H, Jiang Z, Wang H, Wang W, Zhang S, Zhang L.

PLoS One. 2013 Jun 13;8(6):e65536. doi: 10.1371/journal.pone.0065536. Print 2013.

PMID:
23785433
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Effect of oral administration of CpG ODN-OVA on WBB6F1-W/Wv mice.

Teshima R, Okunuki H, Sato Y, Akiyama H, Maitani T, Sawada J.

Allergol Int. 2006 Mar;55(1):43-8.

PMID:
17075285
[PubMed - indexed for MEDLINE]
Free Article
14.

CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.

Kumar S, Jones TR, Oakley MS, Zheng H, Kuppusamy SP, Taye A, Krieg AM, Stowers AW, Kaslow DC, Hoffman SL.

Infect Immun. 2004 Feb;72(2):949-57.

PMID:
14742540
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice.

Badiee A, Jaafari MR, Samiei A, Soroush D, Khamesipour A.

Clin Vaccine Immunol. 2008 Apr;15(4):668-74. doi: 10.1128/CVI.00413-07. Epub 2008 Jan 30.

PMID:
18235040
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice.

Hirunpetcharat C, Mahakunkijcharoen Y, Jeamwattanalert P, Kittigul L, Mahannop P, Pichyangkul S.

Asian Pac J Allergy Immunol. 2011 Sep;29(3):252-9.

PMID:
22053595
[PubMed - indexed for MEDLINE]
Free Article
17.

Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.

Wang Q, Tan MT, Keegan BP, Barry MA, Heffernan MJ.

Biomaterials. 2014 Sep;35(29):8385-93. doi: 10.1016/j.biomaterials.2014.05.067. Epub 2014 Jun 27.

PMID:
24986256
[PubMed - in process]
18.

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.

Ioannou XP, Gomis SM, Karvonen B, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S.

Vaccine. 2002 Nov 22;21(1-2):127-37.

PMID:
12443671
[PubMed - indexed for MEDLINE]
19.
20.

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity.

Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV.

J Exp Med. 1997 Nov 17;186(10):1623-31.

PMID:
9362523
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk